# Ingredion buys Tate & Lyle for $3.6 billion — grab the buyout premium

_AI-generated trading idea · LONG · TATEF, TATYY_

> Canonical page: https://commonquant.ai/research/for-you/ingredion-buys-tate-lyle-for-3-6-billion-grab-the-buyout-pre--a52758ce-e66f-475f-ad50-5f9f28aa9fec

Ingredion is buying Tate & Lyle for $3.6 billion, removing the famous UK company from the stock market.

## Idea

When a company is acquired, its stock price usually jumps to match the buyout offer. Ingredion is paying a premium to buy Tate & Lyle, which means Tate & Lyle shares will likely surge toward that offer price. If the deal is guaranteed to go through, buying the stock now is like picking up money off the table. This is a classic buyout play where the buyer is paying big for the company's valuable food science formulas.

## Advanced Analysis

### Verdict: a real $3.6B bid, but nothing to buy yet

The verdict is \*\*wait\*\*: this is a watch-list setup, not a live signal. The strongest point for the idea is real — Bloomberg's June 8, 2026 coverage confirms Ingredion's $3.6 billion bid for Tate & Lyle, and the target's fundamentals support deal completion, with revenue up 15.6% to $2.01B, operating margin doubled to 12.2%, and free cash flow more than doubled to $105 million in the fiscal year ended March 31, 2026. The strongest point against is that the compiled entry has never fired — zero trades across 1,235 evaluated daily bars over 60 months — and the price-based entry condition sits $33.02 away from the $30.02 close, so the setup only becomes actionable on a dip that tags the $29.69 first support intraday while RSI (now 43.3) clears 45. Meanwhile, gross margin fell to 31.1% from 40.7%, net income dropped 32.2% to $97 million, and debt-to-equity has climbed from 0.43 to 0.77 over two years, a weaker hand if regulators push back on the deal. The parameter-sensitivity review ran out of its time budget, so no robust setup was established — the thresholds are the author's choice, not an optimized sweet spot. A fresh regulatory clearance announcement or deal-milestone SEC filing (neither TATEF nor TATYY has any deal-related filing on file) would be the fact that flips this verdict.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 55/100 |
| Trade readiness | 20/100 |
| Risk quality | 40/100 |
| Trigger proximity | 35/100 |
| Fundamentals trend | 45/100 |
| Score | 39/100 |
| Composite Score | 39/100 |
| Evidence Tier | rules\_not\_triggered |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | rules\_not\_triggered |

### Trade now

Nothing to buy yet. TATYY closed at $30.02, and the entry needs one condition that is nowhere near live: a close below -$3, which is currently $33.02 away from the market. The rest of the entry stack is close or already met — the 14-day RSI at 43.3 is only about 1.7 points below the 45 threshold, price is already above the 30-day average ($30.02 vs $29.97), and the low-tagging condition needs a dip to the first support level at $29.69 with the close holding above it. In plain terms: wait for a shallow pullback that tags $29.69 intraday while momentum turns up above 45. Until then, this is a watch-list setup, not an active signal.

If it does trigger, the risk math is defined by the exits. The first take-profit sits at the nearest resistance, $30.06, and the fixed take-profit fires at +4.9%; the hard stop is at -2.5%, with the structural stop below the second support level at $29.11. That is roughly a 2-to-1 reward-to-risk on the fixed brackets. Position sizing is capped at 25% of the account with about 2.5% risk per trade, so any entry should be modest.

Two caveats before you commit capital. First, the parameter-sensitivity review did not establish a robust setup — the analysis ran out of its time budget, so treat these exact thresholds as the author's choice, not an optimized sweet spot. Second, the idea's core catalyst — Ingredion's $3.6B buyout of Tate & Lyle — is a thesis claim from the idea itself; the entry rules here are a technical pullback setup around it, and the fundamentals filed for the year ended March 2026 (gross margin down to 31.1% from 40.7%, net income down 32% to $97M) are a live reminder that the underlying business is under pressure. "Wait" means: check the daily close, and act only if all five entry conditions line up on the same bar.

#### TATYY price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | TATYY |
| Timeframe | 1d |

### A real premium on the table — and fundamentals that don't get in the way

The idea's core logic is a classic one: when a buyer pays a premium, the target's price gravitates toward the offer as the deal gains certainty. The Bloomberg coverage of June 8, 2026 confirms the setup is real — Ingredion announced a $3.6 billion takeover of Tate & Lyle, the kind of event the article's 'M&A Monday' segment framed as a genuine, funded bid rather than speculation. A long bias in TATYY ahead of deal completion is the direction the thesis calls for, and nothing in the fundamentals undermines the buyer's ability to pay: the target carries $344 million in cash against $1.23 billion of long-term debt, a debt-to-equity ratio of 0.77, and a current ratio of 2.71 — a balance sheet a strategic acquirer can absorb without strain. The latest fiscal year (ended March 31, 2026) actually shows a business inflecting upward where it matters for a deal. Revenue rose 15.6% to $2.01 billion, operating margin more than doubled from 6.1% to 12.2%, operating cash flow jumped 40% to $230 million, and free cash flow more than doubled to $105 million. For a merger-arb thesis, the relevant question is whether deteriorating fundamentals could give regulators or the board a reason to walk — and here, a growing, cash-generative target makes deal completion more, not less, likely. Important honesty about the strategy itself: the entry rules were evaluated on real daily bars across 60 months (1,235 bars, plus 24- and 12-month windows) and…

#### TATYY Free cash flow

Free cash flow trend from CommonQuant fundamentals/XBRL data; +975.0% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2023-03-31 | $-12000000 |
| 2024-03-31 | $98000000 |
| 2025-03-31 | $43000000 |
| 2026-03-31 | $105000000 |
| Latest Value | $105000000 |
| Change Pct | $975 |
| Ticker | TATYY |
| Timeframe | reported periods |

#### TATYY Revenue

Revenue trend from CommonQuant fundamentals/XBRL data; +14.6% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2023-03-31 | $1751000000 |
| 2024-03-31 | $1647000000 |
| 2025-03-31 | $1736000000 |
| 2026-03-31 | $2006000000 |
| Latest Value | $2006000000 |
| Change Pct | $14.563106796116504 |
| Ticker | TATYY |
| Timeframe | reported periods |

### Scores

- **Conviction score breakdown:** 39
- **Thesis support:** 55
- **Trade readiness:** 20
- **Risk quality:** 40
- **Trigger proximity:** 35
- **Fundamentals trend:** 45

### Watch items

- **TATYY — RSI (14)**
- **TATYY — Close price**
- **TATYY — Intraday low vs first support**
- **TATYY — Price vs first resistance**
- **TATYY — Close vs second support**
- **TATYY — Position drawdown**
- **TATYY — Annual XBRL filing (FY ending 2027-03-31)**
- **TATYY — Deal regulatory milestone (Ingredion $3.6B acquisition)**
- **TATYY — Price below -3**
- **TATYY — RSI (14) above 45**
- **TATYY — SMA (30) below Price**
- **TATYY — RSI (14) below 30**
- **TATYY — Price above -0.5**

## Key details

- Symbols: TATEF, TATYY
- Timeframes: 1D
- Tags: \#mergers, \#europe, \#value

## Community

- Upvotes: 8
- Views: 0
- Copies: 0
- Cosigns: 0

## News sources

- [M&A Monday: Intesa's €31 Billion Bid for Paschi & Tate & Lyle Takeover \| The Opening Trade 6/8/2026](https://www.bloomberg.com/news/videos/2026-06-08/the-opening-trade-6-8-2026-video) — Bloomberg

## Related

- [TATEF trade ideas](https://commonquant.ai/markets/tatef)
- [TATYY trade ideas](https://commonquant.ai/markets/tatyy)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.